EIP
UTHR icon

Epoch Investment Partners’s United Therapeutics UTHR Stock Holding History

Epoch Investment Partners’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$81.6M Buy
150,644
+29,962
+25% +$16.9M 0.46% 79
2026
Q1 		$71.6M Sell
120,682
-21,610
-15% -$10.8M 0.43% 92
2025
Q4 		$69.3M Sell
142,292
-63,490
-31% -$29.6M 0.39% 98
2025
Q3 		$86.3M Sell
205,782
-85,712
-29% -$28.8M 0.47% 80
2025
Q2 		$83.8M Buy
291,494
+5,621
+2% +$1.68M 0.43% 87
2025
Q1 		$88.1M Buy
285,873
+59,661
+26% +$20.4M 0.46% 79
2024
Q4 		$79.8M Sell
226,212
-12,574
-5% -$4.62M 0.39% 89
2024
Q3 		$85.6M Buy
238,786
+12,131
+5% +$4.1M 0.38% 98
2024
Q2 		$72.2M Buy
226,655
+13,157
+6% +$3.48M 0.33% 107
2024
Q1 		$49M Buy
213,498
+319
+0.1% +$72K 0.22% 166
2023
Q4 		$46.9M Buy
213,179
+75,400
+55% +$17.4M 0.21% 170
2023
Q3 		$31.1M Sell
137,779
-6,986
-5% -$1.61M 0.2% 161
2023
Q2 		$32M Sell
144,765
-4,512
-3% -$999K 0.19% 171
2023
Q1 		$33.4M Sell
149,277
-49,521
-25% -$12.2M 0.2% 165
2022
Q4 		$55.3M Sell
198,798
-71,344
-26% -$18M 0.33% 103
2022
Q3 		$56.6M Sell
270,142
-26,243
-9% -$5.87M 0.37% 95
2022
Q2 		$69.8M Sell
296,385
-60,554
-17% -$12.3M 0.41% 81
2022
Q1 		$64M Buy
356,939
+27,652
+8% +$5.27M 0.31% 107
2021
Q4 		$71.2M Buy
329,287
+73,816
+29% +$14.5M 0.36% 95
2021
Q3 		$47.2M Buy
+255,471
New +$50.3M 0.26% 122
2017
Q2 		– Sell
-37,258
Closed -$5.04M – 318
2017
Q1 		$5.04M Hold
37,258
– – 0.02% 250
2016
Q4 		$5.34M Buy
+37,258
New +$4.76M 0.02% 203

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Epoch Investment Partners's UTHR Position: Q2 2026 in Review

Epoch Investment Partners increased its United Therapeutics (UTHR) stake by 25% in Q2 2026, buying an estimated $16.9M and bringing the position to 150,644 shares worth $81.6M. The position accounts for 0.46% of the portfolio, ranked #79.

Epoch Investment Partners first reported a position in UTHR in Q4 2016 and has held it in 22 quarters since. The position peaked at $88.1M in Q1 2025. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Epoch Investment Partners held 150,644 shares of United Therapeutics worth $81.6M as of Q2 2026.
  • Epoch Investment Partners bought 29,962 United Therapeutics shares in Q2 2026, an estimated $16.9M.
  • United Therapeutics made up 0.46% of Epoch Investment Partners's portfolio in Q2 2026, its #79 holding.
  • Epoch Investment Partners first reported a position in United Therapeutics in Q4 2016 and has held it in 22 quarters since.
  • Epoch Investment Partners's United Therapeutics position peaked at $88.1M in Q1 2025.
  • 878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Epoch Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.